Digitisation | April 19, 2024
Dr. Reddy’s launches integrated care plan to manage irritable bowel syndrome
Around 7% of the Indian population suffers from IBS
Around 7% of the Indian population suffers from IBS
_256_384.jpg)
The regulator carried out a routine current Good Manufacturing Practices (cGMP) inspection from March 28 to April 4.
MoU to serve as the establishment of an Academic Collaboration in Ayurveda and Thai Traditional Medicine
The preventive and promotive approach of our traditional health care systems has played a significant role in modern age today
he lower sales in the current quarter are mainly on account of a one?time impact on the company’s India business
Developed by Pfizer, Abrocitinib has received marketing authorization from the Central Drugs Standard Control Organization (CDSCO) in India
The company disclosed that several employees of a subsidiary had their business email addresses stolen
This combination aims to offer an effective tool to manage symptoms of nausea and vomiting during pregnancy
The product will be manufactured at Lupin's Pithampur facility in India
Announces changes to commercial organization to prepare for multiple product launches in 2024 and 2025
Subscribe To Our Newsletter & Stay Updated
